ROYAL BANK OF CANADA - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$402,000
+140.7%
14,746
+96.4%
0.00%
Q2 2023$167,000
-69.7%
7,507
-70.6%
0.00%
Q1 2023$552,000
+23.2%
25,519
+15.4%
0.00%
Q4 2022$448,000
+143.5%
22,104
+208.5%
0.00%
Q3 2022$184,000
-45.9%
7,166
-49.9%
0.00%
Q2 2022$340,000
+117.9%
14,314
+106.2%
0.00%
Q1 2022$156,000
-58.2%
6,941
-63.2%
0.00%
Q4 2021$373,000
-71.5%
18,881
-71.6%
0.00%
Q3 2021$1,310,000
-16.3%
66,586
-6.4%
0.00%
Q2 2021$1,565,000
-16.0%
71,141
-9.2%
0.00%
-100.0%
Q1 2021$1,863,000
-49.5%
78,312
-44.4%
0.00%0.0%
Q4 2020$3,686,000
+5.3%
140,929
-30.0%
0.00%0.0%
Q3 2020$3,502,000
-0.5%
201,216
-3.9%
0.00%0.0%
Q2 2020$3,521,000
+41.6%
209,308
+0.1%
0.00%0.0%
Q1 2020$2,486,000
+465.0%
209,032
+475.0%
0.00%
Q4 2019$440,000
-13.7%
36,351
+0.6%
0.00%
Q3 2019$510,000
+26.2%
36,151
-0.4%
0.00%
Q2 2019$404,000
+42.8%
36,294
+50.9%
0.00%
Q1 2019$283,000
-40.3%
24,057
-32.2%
0.00%
Q4 2018$474,000
-11.4%
35,459
-8.5%
0.00%
Q3 2018$535,000
+3243.8%
38,753
+3775.3%
0.00%
Q2 2018$16,000
-15.8%
1,000
-15.8%
0.00%
Q1 2018$19,000
-24.0%
1,187
-14.4%
0.00%
Q4 2017$25,000
-95.0%
1,387
-94.7%
0.00%
Q3 2017$505,000
+91.3%
26,183
+17.2%
0.00%
Q2 2017$264,000
+91.3%
22,335
+76.9%
0.00%
Q1 2017$138,000
-54.2%
12,627
-69.5%
0.00%
Q4 2016$301,000
+30000.0%
41,465
+27728.9%
0.00%
Q4 2015$1,000
-90.9%
149
-95.1%
0.00%
Q3 2015$11,000
-38.9%
3,040
+3.8%
0.00%
Q2 2015$18,000
+800.0%
2,929
+632.2%
0.00%
Q1 2014$2,000
+100.0%
4000.0%0.00%
Q4 2013$1,0000.0%4000.0%0.00%
Q3 2013$1,0004000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders